1. Diamino dichlorophenyl pyrimidines in mouse leukemia;Burchenal;Cancer Res,1952
2. Phase I trial of metoprine in patients with advanced cancer;Currie;Cancer Treat Rep,1980
3. Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW301U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines;Sedwick;Molec Pharmacol,1982
4. Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethyoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW301U), a novel lipid soluble inhibitor of dihydrofolate reductase;Duch;Cancer Res,1982
5. Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine;Grivsky;J Med Chem,1980